NafoA.00379.a
enolase family protein
CENTER ID:
NafoA.00379.a
ORGANISM:
Naegleria fowleri ATCC 30863
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIB
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
NafoA.00379.a.B4.GE44253
ENO2 truncation 2
info
62
512
NafoA.00379.a.B4.GE44253
NafoA.00379.a.B5.GE44254
ENO2 truncation 3
info
44
512
NafoA.00379.a.B5.GE44254
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
NafoA.00379.a.B4.PW38978
ENO2 truncation 2
info
62
512
PW38978
NafoA.00379.a.B5.PW38980
ENO2 truncation 3
info
44
512
PW38980
NafoA.00379.a.B5.PW39044
ENO2 truncation 3
info
44
512
PW39044
NafoA.00379.a.B5.PW39046
ENO2 truncation 3
info
44
512
PW39046
NafoA.00379.a.B4.PW39047
ENO2 truncation 2
info
62
512
PW39047
Structures
7UGH
DEPOSITED: 3/24/2022
DETERMINATION: XRay
CLONE: NafoA.00379.a.B5.GE44254
PROTEIN: NafoA.00379.a.B5.PW38980
Publications by SSGCID
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
Phan IQ, Staker B, Weiss MS, Milanes JE, Morris JC, Harding EM, Yin X, Jebet A
PLoS Pathog. - 2024
volume 8, issue 2024 Aug 1,
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MLYLVLMLVE NGFGQNCFLH SQKICSNMTD KQPVSEYLQN HNLQKLVEDA LNECYNANAS DPVGFLGHFF LNRGKKGAVN RVDKLVGREI LDSRGNPTVE VDVYANGQKR PVATASAPSG ASTGSNEAHE LRDGDKSRYL GKGVLKAVKN VNDVLGKAVE GKSLENLTEL DQALIDADGD ELKSNLGGNA ITACSFALAT AGAAVRNEEL FLYLARAFHG ADKFENLKFR LPTPMVNILN GGKHAGGRLQ IQEFMILPKE NQPFREKVRC VAEVYQHLGK ILAERAGPSA KNVGDEGGFA PNLETADEAL NYIEEAIGKA GYKVGEDVFL ALDAASSEFY NSDTKKYEIT QQKEFLTSEE MVEYYVQLVN RHPAIISIED GLEEKDYEGW KLLTERLGSK IMLVGDDLYT TNTRLIKQGI EEKWANALLL KVNQIGTITE AMNAARMIFN VGQKVIVSHR SGETATTLIS DLVVGIGATH IKTGATARGE RVSKYNRLLQ IEEYLEQHGL LA
NT Sequence
ATGCTTTATT TGGTGCTTAT GCTTGTTGAG AATGGGTTTG GCCAAAATTG TTTTCTTCAC AGCCAAAAAA TTTGCTCCAA CATGACCGAT AAACAACCAG TCAGTGAATA TCTTCAAAAT CACAATCTTC AAAAGTTGGT TGAAGATGCT CTCAATGAAT GCTACAATGC CAACGCCAGT GATCCCGTTG GATTCCTTGG TCACTTCTTT TTGAACCGTG GAAAGAAGGG TGCTGTCAAT CGTGTCGACA AGCTTGTTGG TAGAGAAATT TTGGATTCAA GAGGTAATCC AACGGTTGAA GTTGACGTTT ATGCTAATGG ACAAAAGAGA CCAGTAGCCA CTGCTTCTGC ACCATCCGGA GCAAGTACAG GAAGCAATGA AGCTCACGAA CTTCGTGATG GTGATAAATC AAGATACCTC GGAAAAGGTG TTTTGAAAGC TGTGAAGAAT GTGAATGATG TGTTGGGCAA GGCAGTGGAA GGAAAGTCAT TGGAAAACTT GACAGAACTC GATCAAGCTT TGATCGATGC TGATGGTGAT GAGTTGAAGA GCAATTTGGG AGGTAATGCG ATCACTGCAT GCAGTTTTGC ACTTGCCACT GCTGGTGCTG CTGTCAGAAA TGAGGAATTG TTCTTGTACT TGGCAAGAGC ATTCCATGGA GCTGATAAGT TTGAAAACTT AAAGTTCCGT TTGCCTACTC CTATGGTCAA CATTTTGAAT GGAGGTAAAC ACGCAGGTGG TCGTCTCCAA ATTCAAGAAT TTATGATTTT ACCAAAGGAA AATCAACCAT TCCGTGAGAA GGTGAGATGT GTCGCTGAAG TTTATCAACA TTTGGGTAAG ATTCTTGCTG AGAGAGCTGG TCCAAGTGCA AAGAACGTTG GTGATGAAGG AGGATTTGCA CCAAACTTGG AAACTGCTGA TGAAGCATTG AATTATATCG AGGAAGCAAT TGGCAAGGCA GGCTACAAGG TTGGCGAAGA TGTGTTTTTG GCTTTGGATG CTGCTTCAAG TGAGTTCTAC AACTCGGACA CAAAGAAGTA TGAAATTACT CAACAAAAAG AGTTCTTGAC CTCCGAAGAA ATGGTTGAAT ATTATGTTCA ATTGGTCAAT AGACACCCTG CTATTATCTC CATTGAAGAT GGATTGGAAG AAAAGGATTA TGAAGGATGG AAACTTTTGA CTGAAAGATT AGGATCAAAG ATCATGTTGG TTGGTGATGA TTTGTACACA ACAAATACCA GATTAATCAA GCAAGGAATT GAGGAAAAGT GGGCAAATGC TTTGTTGTTG AAGGTTAACC AAATTGGTAC CATCACCGAA GCAATGAATG CTGCCAGAAT GATTTTCAAT GTTGGACAAA AGGTTATTGT TTCGCATAGA TCCGGTGAGA CTGCAACCAC TTTAATCTCT GACTTGGTGG TTGGTATTGG AGCCACACAC ATTAAGACTG GTGCTACTGC TAGAGGAGAA CGTGTATCCA AGTACAACCG ATTGTTGCAA ATCGAAGAAT ATCTTGAACA ACACGGTTTG CTTGCA
Details for NafoA.00379.a.B4.GE44253
HARVESTED ON:
4/1/2021
SEQUENCED ON:
4/13/2021
EXPECTED MW:
50kDa
OBSERVED MW:
50kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for NafoA.00379.a.B5.GE44254
HARVESTED ON:
4/1/2021
SEQUENCED ON:
4/13/2021
EXPECTED MW:
52kDa
OBSERVED MW:
52kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
95
PERCENT COVERAGE:
63
Details for NafoA.00379.a.B4.PW38978
PURIFICATION DATe:
4/19/2021
CONCENTRATION:
26mg/ml
OBSERVED MW:
50kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
8
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for NafoA.00379.a.B5.PW38980
PURIFICATION DATe:
4/21/2021
CONCENTRATION:
36mg/ml
OBSERVED MW:
52kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
6
VIAL VOLUME:
200µl
PERCENT IDENTITY:
95
PERCENT COVERAGE:
63
Details for NafoA.00379.a.B5.PW39044
PURIFICATION DATe:
6/11/2021
CONCENTRATION:
54mg/ml
OBSERVED MW:
52kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
4
VIAL VOLUME:
50µl
PERCENT IDENTITY:
95
PERCENT COVERAGE:
63
Details for NafoA.00379.a.B5.PW39046
PURIFICATION DATe:
6/25/2021
CONCENTRATION:
73mg/ml
OBSERVED MW:
52kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
4
VIAL VOLUME:
52µl
PERCENT IDENTITY:
95
PERCENT COVERAGE:
63
Details for NafoA.00379.a.B4.PW39047
PURIFICATION DATe:
7/22/2021
CONCENTRATION:
45mg/ml
OBSERVED MW:
50kDa
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
6
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable